

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.71795887 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.38681079 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.38681079 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.32916864 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.32916864 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.06953168 |
| 7 | high-density lipoprotein particle remodeling (GO:0034375) | 5.92250545 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.87534097 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.87534097 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.87534097 |
| 11 | regulation of cholesterol esterification (GO:0010872) | 5.67381814 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.54564414 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.47680325 |
| 14 | phospholipid efflux (GO:0033700) | 5.40785998 |
| 15 | reverse cholesterol transport (GO:0043691) | 5.27085028 |
| 16 | urea cycle (GO:0000050) | 5.25865721 |
| 17 | urea metabolic process (GO:0019627) | 5.25865721 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.25276138 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.16412854 |
| 20 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.12228731 |
| 21 | protein-lipid complex remodeling (GO:0034368) | 5.05990048 |
| 22 | macromolecular complex remodeling (GO:0034367) | 5.05990048 |
| 23 | plasma lipoprotein particle remodeling (GO:0034369) | 5.05990048 |
| 24 | regulation of triglyceride catabolic process (GO:0010896) | 4.99351588 |
| 25 | triglyceride homeostasis (GO:0070328) | 4.98524889 |
| 26 | acylglycerol homeostasis (GO:0055090) | 4.98524889 |
| 27 | bile acid biosynthetic process (GO:0006699) | 4.96886331 |
| 28 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.95642863 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.83487925 |
| 30 | regulation of plasminogen activation (GO:0010755) | 4.82002840 |
| 31 | regulation of apoptotic cell clearance (GO:2000425) | 4.80906981 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.79220374 |
| 33 | * cholesterol efflux (GO:0033344) | 4.75642822 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.73439240 |
| 35 | protein carboxylation (GO:0018214) | 4.73439240 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 4.72380318 |
| 37 | regulation of fibrinolysis (GO:0051917) | 4.72032050 |
| 38 | negative regulation of sterol transport (GO:0032372) | 4.69032045 |
| 39 | negative regulation of cholesterol transport (GO:0032375) | 4.69032045 |
| 40 | bile acid metabolic process (GO:0008206) | 4.61927606 |
| 41 | positive regulation of steroid metabolic process (GO:0045940) | 4.60926224 |
| 42 | diacylglycerol metabolic process (GO:0046339) | 4.60413518 |
| 43 | regulation of protein activation cascade (GO:2000257) | 4.54137879 |
| 44 | cysteine metabolic process (GO:0006534) | 4.52709888 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 4.50339201 |
| 46 | alpha-linolenic acid metabolic process (GO:0036109) | 4.48151948 |
| 47 | * plasma lipoprotein particle assembly (GO:0034377) | 4.44795104 |
| 48 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.44096550 |
| 49 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.44096550 |
| 50 | imidazole-containing compound metabolic process (GO:0052803) | 4.39260239 |
| 51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.36880246 |
| 52 | complement activation, alternative pathway (GO:0006957) | 4.36803722 |
| 53 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.33887383 |
| 54 | cellular biogenic amine catabolic process (GO:0042402) | 4.33538221 |
| 55 | amine catabolic process (GO:0009310) | 4.33538221 |
| 56 | homocysteine metabolic process (GO:0050667) | 4.27193800 |
| 57 | * cholesterol transport (GO:0030301) | 4.25762509 |
| 58 | * sterol transport (GO:0015918) | 4.25762509 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.22238085 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.21728077 |
| 61 | cellular glucuronidation (GO:0052695) | 4.21370832 |
| 62 | NAD biosynthetic process (GO:0009435) | 4.19891791 |
| 63 | * intestinal cholesterol absorption (GO:0030299) | 4.19566557 |
| 64 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.19115123 |
| 65 | regulation of complement activation (GO:0030449) | 4.16149367 |
| 66 | regulation of bile acid biosynthetic process (GO:0070857) | 4.12292741 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 4.11960935 |
| 68 | drug catabolic process (GO:0042737) | 4.08987642 |
| 69 | alpha-amino acid catabolic process (GO:1901606) | 4.08590780 |
| 70 | proline metabolic process (GO:0006560) | 4.07940562 |
| 71 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.07085008 |
| 72 | tyrosine metabolic process (GO:0006570) | 4.06263557 |
| 73 | amino-acid betaine metabolic process (GO:0006577) | 4.06109938 |
| 74 | lipoprotein transport (GO:0042953) | 4.04913894 |
| 75 | low-density lipoprotein particle remodeling (GO:0034374) | 4.02830974 |
| 76 | proline biosynthetic process (GO:0006561) | 4.01184923 |
| 77 | lipoprotein metabolic process (GO:0042157) | 4.00504640 |
| 78 | * very-low-density lipoprotein particle assembly (GO:0034379) | 3.98759615 |
| 79 | * cholesterol homeostasis (GO:0042632) | 3.89647116 |
| 80 | glycine metabolic process (GO:0006544) | 3.88104375 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 3.88098470 |
| 82 | * plasma lipoprotein particle organization (GO:0071827) | 3.88042707 |
| 83 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.85748227 |
| 84 | negative regulation of sodium ion transport (GO:0010766) | 3.83757740 |
| 85 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.83660451 |
| 86 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.83660451 |
| 87 | trivalent inorganic anion homeostasis (GO:0072506) | 3.81660788 |
| 88 | phosphate ion homeostasis (GO:0055062) | 3.81660788 |
| 89 | * protein-lipid complex assembly (GO:0065005) | 3.81428937 |
| 90 | * sterol homeostasis (GO:0055092) | 3.81146067 |
| 91 | modified amino acid transport (GO:0072337) | 3.80859016 |
| 92 | cellular amino acid catabolic process (GO:0009063) | 3.74217838 |
| 93 | uronic acid metabolic process (GO:0006063) | 3.72905568 |
| 94 | glucuronate metabolic process (GO:0019585) | 3.72905568 |
| 95 | response to nitrosative stress (GO:0051409) | 3.72804434 |
| 96 | negative regulation of protein activation cascade (GO:2000258) | 3.71700507 |
| 97 | arginine metabolic process (GO:0006525) | 3.70966227 |
| 98 | serine family amino acid metabolic process (GO:0009069) | 3.70839254 |
| 99 | low-density lipoprotein particle clearance (GO:0034383) | 3.70121723 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 3.68192382 |
| 101 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.66365993 |
| 102 | * lipid homeostasis (GO:0055088) | 3.65893074 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.60820525 |
| 104 | phospholipid homeostasis (GO:0055091) | 3.59387512 |
| 105 | flavonoid metabolic process (GO:0009812) | 3.59106009 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.58669888 |
| 107 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.58636994 |
| 108 | * protein-lipid complex subunit organization (GO:0071825) | 3.55918706 |
| 109 | serine family amino acid biosynthetic process (GO:0009070) | 3.55891178 |
| 110 | lysine metabolic process (GO:0006553) | 3.54817914 |
| 111 | lysine catabolic process (GO:0006554) | 3.54817914 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.52231923 |
| 113 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.52002861 |
| 114 | cellular ketone body metabolic process (GO:0046950) | 3.52001016 |
| 115 | cytolysis (GO:0019835) | 3.48786312 |
| 116 | coenzyme catabolic process (GO:0009109) | 3.47991332 |
| 117 | lung epithelium development (GO:0060428) | 3.47939833 |
| 118 | negative regulation of hemostasis (GO:1900047) | 3.46504669 |
| 119 | negative regulation of blood coagulation (GO:0030195) | 3.46504669 |
| 120 | heme transport (GO:0015886) | 3.45053754 |
| 121 | glutamate metabolic process (GO:0006536) | 3.43776658 |
| 122 | * intestinal absorption (GO:0050892) | 3.42501106 |
| 123 | aldehyde catabolic process (GO:0046185) | 3.41148745 |
| 124 | alkaloid metabolic process (GO:0009820) | 3.36991939 |
| 125 | cellular zinc ion homeostasis (GO:0006882) | 3.34350304 |
| 126 | regulation of cholesterol metabolic process (GO:0090181) | 3.31305269 |
| 127 | drinking behavior (GO:0042756) | 3.29710804 |
| 128 | neutral lipid catabolic process (GO:0046461) | 3.29498739 |
| 129 | acylglycerol catabolic process (GO:0046464) | 3.29498739 |
| 130 | positive regulation of extracellular matrix organization (GO:1903055) | 3.24086381 |
| 131 | nephron tubule morphogenesis (GO:0072078) | 3.18541740 |
| 132 | nephron epithelium morphogenesis (GO:0072088) | 3.18541740 |
| 133 | negative regulation of coagulation (GO:0050819) | 3.17622965 |
| 134 | L-ascorbic acid metabolic process (GO:0019852) | 3.17412600 |
| 135 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.15649083 |
| 136 | oligosaccharide catabolic process (GO:0009313) | 3.15438490 |
| 137 | acute-phase response (GO:0006953) | 3.15216362 |
| 138 | regulation of extracellular matrix organization (GO:1903053) | 3.12923991 |
| 139 | anion homeostasis (GO:0055081) | 3.09376888 |
| 140 | fibrinolysis (GO:0042730) | 3.08690511 |
| 141 | positive regulation of hormone metabolic process (GO:0032352) | 3.07371404 |
| 142 | C21-steroid hormone metabolic process (GO:0008207) | 3.07355534 |
| 143 | positive regulation of hemostasis (GO:1900048) | 3.07051576 |
| 144 | positive regulation of blood coagulation (GO:0030194) | 3.07051576 |
| 145 | regulation of humoral immune response (GO:0002920) | 3.06815733 |
| 146 | vitamin transmembrane transport (GO:0035461) | 3.02061224 |
| 147 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.99449235 |
| 148 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.99044612 |
| 149 | cellular anion homeostasis (GO:0030002) | 2.93147898 |
| 150 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.91337858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.73565537 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.87279807 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.70645459 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.88557439 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.39639499 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.97921090 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.38480000 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.19712909 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74828019 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.35210720 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.93275993 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1650784 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95470122 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.91626311 |
| 15 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.90459802 |
| 16 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.75451957 |
| 17 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.73284040 |
| 18 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.62623577 |
| 19 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.60793617 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.55669653 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50638882 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39921538 |
| 23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37037848 |
| 24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.34745077 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34176296 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30519648 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27805575 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27481401 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26934108 |
| 30 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.25149891 |
| 31 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.23315036 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21478567 |
| 33 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.19497823 |
| 34 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.18529594 |
| 35 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.18466545 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18240070 |
| 37 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13768456 |
| 38 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.11116855 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09220931 |
| 40 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.08610974 |
| 41 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.06902740 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04952160 |
| 43 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.01865532 |
| 44 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99066245 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98460631 |
| 46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98076568 |
| 47 | P68_20966046_ChIP-Seq_HELA_Human | 0.95961951 |
| 48 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95869235 |
| 49 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93076981 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92921663 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92289992 |
| 52 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.91963495 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91385675 |
| 54 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91258809 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.90158678 |
| 56 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89805914 |
| 57 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89539974 |
| 58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.88834058 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88116249 |
| 60 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.88007527 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86571670 |
| 62 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.86533985 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86283543 |
| 64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86250024 |
| 65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85607869 |
| 66 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85583070 |
| 67 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.84696613 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83265306 |
| 69 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.82622879 |
| 70 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.81806268 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.80942199 |
| 72 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80144278 |
| 73 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79850061 |
| 74 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.79528621 |
| 75 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.79286978 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78944301 |
| 77 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.78711457 |
| 78 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.78503898 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77148908 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76604969 |
| 81 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.75731788 |
| 82 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.75417959 |
| 83 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75131611 |
| 84 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.74506482 |
| 85 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74223781 |
| 86 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.73551690 |
| 87 | * SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.73278112 |
| 88 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.73183869 |
| 89 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.72839641 |
| 90 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.72776622 |
| 91 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.71838993 |
| 92 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.71302079 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70966958 |
| 94 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.70724013 |
| 95 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.70533198 |
| 96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70075945 |
| 97 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.68070051 |
| 98 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.67305704 |
| 99 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67057616 |
| 100 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66641687 |
| 101 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.66145352 |
| 102 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.66037788 |
| 103 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.65746592 |
| 104 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.65716737 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.65268430 |
| 106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.64869194 |
| 107 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.64157409 |
| 108 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.63771286 |
| 109 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.63733407 |
| 110 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.63316855 |
| 111 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63086163 |
| 112 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.63023164 |
| 113 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62474096 |
| 114 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.62315674 |
| 115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.61977213 |
| 116 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.60965531 |
| 117 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.60715770 |
| 118 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.60459828 |
| 119 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.59915835 |
| 120 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.59427399 |
| 121 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.58198462 |
| 122 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.57174615 |
| 123 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.56916992 |
| 124 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.55347992 |
| 125 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.54994423 |
| 126 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.54439404 |
| 127 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53834522 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.53748957 |
| 129 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.53187354 |
| 130 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.52714721 |
| 131 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52680223 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52280335 |
| 133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.52069170 |
| 134 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51430436 |
| 135 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51073685 |
| 136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.50589408 |
| 137 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.50244627 |
| 138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.50127537 |
| 139 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.50107976 |
| 140 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.49923979 |
| 141 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.49399176 |
| 142 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.49391904 |
| 143 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.48620265 |
| 144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47886507 |
| 145 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47547263 |
| 146 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.47068600 |
| 147 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.46251169 |
| 148 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.45765943 |
| 149 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.45765943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.60064050 |
| 2 | MP0005360_urolithiasis | 7.51603174 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.20565988 |
| 4 | MP0005365_abnormal_bile_salt | 5.82847486 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.67269466 |
| 6 | MP0003122_maternal_imprinting | 4.61508792 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.81951315 |
| 8 | MP0003252_abnormal_bile_duct | 3.70562594 |
| 9 | MP0009840_abnormal_foam_cell | 3.31396069 |
| 10 | * MP0010329_abnormal_lipoprotein_level | 3.27502027 |
| 11 | * MP0001666_abnormal_nutrient_absorption | 2.75305589 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.48892932 |
| 13 | MP0003123_paternal_imprinting | 2.46257844 |
| 14 | MP0005332_abnormal_amino_acid | 2.37226903 |
| 15 | MP0003195_calcinosis | 2.32328688 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.22677757 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.22391160 |
| 18 | MP0002089_abnormal_postnatal_growth/wei | 2.22173252 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.17946177 |
| 20 | MP0005083_abnormal_biliary_tract | 2.14629184 |
| 21 | MP0008260_abnormal_autophagy | 2.10392903 |
| 22 | MP0009697_abnormal_copulation | 2.09577906 |
| 23 | * MP0000609_abnormal_liver_physiology | 2.00165922 |
| 24 | MP0001764_abnormal_homeostasis | 1.98049935 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.83959417 |
| 26 | MP0001986_abnormal_taste_sensitivity | 1.82203266 |
| 27 | * MP0002118_abnormal_lipid_homeostasis | 1.79490931 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.66049303 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.58611987 |
| 30 | MP0001915_intracranial_hemorrhage | 1.49789438 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.49156891 |
| 32 | MP0003868_abnormal_feces_composition | 1.43515168 |
| 33 | MP0005451_abnormal_body_composition | 1.41468598 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.38129542 |
| 35 | MP0003186_abnormal_redox_activity | 1.33952667 |
| 36 | MP0006054_spinal_hemorrhage | 1.33410732 |
| 37 | MP0002132_abnormal_respiratory_system | 1.30521407 |
| 38 | MP0003121_genomic_imprinting | 1.30395029 |
| 39 | MP0009384_cardiac_valve_regurgitation | 1.22851472 |
| 40 | MP0005409_darkened_coat_color | 1.21857706 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.20158204 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16052006 |
| 43 | MP0000598_abnormal_liver_morphology | 1.14499117 |
| 44 | MP0004264_abnormal_extraembryonic_tissu | 1.13677097 |
| 45 | MP0009764_decreased_sensitivity_to | 1.13634663 |
| 46 | MP0005647_abnormal_sex_gland | 1.13498509 |
| 47 | MP0002876_abnormal_thyroid_physiology | 1.11142715 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.08638020 |
| 49 | MP0002254_reproductive_system_inflammat | 1.06934437 |
| 50 | MP0003315_abnormal_perineum_morphology | 1.05660301 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.05363718 |
| 52 | MP0003718_maternal_effect | 1.03557873 |
| 53 | MP0003567_abnormal_fetal_cardiomyocyte | 1.03184407 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.02617598 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.01939046 |
| 56 | MP0005084_abnormal_gallbladder_morpholo | 1.01463328 |
| 57 | MP0003878_abnormal_ear_physiology | 1.01027584 |
| 58 | MP0005377_hearing/vestibular/ear_phenot | 1.01027584 |
| 59 | MP0002938_white_spotting | 1.01000860 |
| 60 | MP0008469_abnormal_protein_level | 0.93645456 |
| 61 | MP0003879_abnormal_hair_cell | 0.91448375 |
| 62 | MP0003011_delayed_dark_adaptation | 0.91240240 |
| 63 | MP0004272_abnormal_basement_membrane | 0.91085798 |
| 64 | MP0008057_abnormal_DNA_replication | 0.89428167 |
| 65 | MP0009763_increased_sensitivity_to | 0.89406915 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 0.87655586 |
| 67 | MP0005376_homeostasis/metabolism_phenot | 0.85214494 |
| 68 | * MP0009642_abnormal_blood_homeostasis | 0.83499235 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 0.82911330 |
| 70 | MP0002933_joint_inflammation | 0.80693582 |
| 71 | MP0005408_hypopigmentation | 0.80528576 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 0.80335891 |
| 73 | MP0008438_abnormal_cutaneous_collagen | 0.80157767 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 0.78031940 |
| 75 | MP0003329_amyloid_beta_deposits | 0.77608967 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 0.77049144 |
| 77 | MP0002160_abnormal_reproductive_system | 0.74825310 |
| 78 | MP0005266_abnormal_metabolism | 0.74570240 |
| 79 | MP0001661_extended_life_span | 0.74497819 |
| 80 | MP0006082_CNS_inflammation | 0.74220221 |
| 81 | MP0005670_abnormal_white_adipose | 0.73419497 |
| 82 | MP0005410_abnormal_fertilization | 0.73130569 |
| 83 | MP0001270_distended_abdomen | 0.72446671 |
| 84 | MP0005334_abnormal_fat_pad | 0.71131202 |
| 85 | MP0009053_abnormal_anal_canal | 0.69691804 |
| 86 | MP0003942_abnormal_urinary_system | 0.69123533 |
| 87 | MP0003724_increased_susceptibility_to | 0.67967222 |
| 88 | MP0005448_abnormal_energy_balance | 0.67453453 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.65567300 |
| 90 | MP0003115_abnormal_respiratory_system | 0.65424181 |
| 91 | MP0003943_abnormal_hepatobiliary_system | 0.64325397 |
| 92 | MP0003436_decreased_susceptibility_to | 0.63920986 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.63683759 |
| 94 | MP0004147_increased_porphyrin_level | 0.62371621 |
| 95 | MP0001293_anophthalmia | 0.60501395 |
| 96 | MP0009115_abnormal_fat_cell | 0.60280538 |
| 97 | MP0000639_abnormal_adrenal_gland | 0.59685468 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.59407274 |
| 99 | MP0000566_synostosis | 0.59011290 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.57887983 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.57715719 |
| 102 | MP0005395_other_phenotype | 0.57612422 |
| 103 | MP0010155_abnormal_intestine_physiology | 0.57088578 |
| 104 | MP0002086_abnormal_extraembryonic_tissu | 0.56219308 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.56144877 |
| 106 | MP0002971_abnormal_brown_adipose | 0.55473734 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.54944406 |
| 108 | MP0003941_abnormal_skin_development | 0.54023345 |
| 109 | MP0004883_abnormal_blood_vessel | 0.53188743 |
| 110 | MP0001845_abnormal_inflammatory_respons | 0.52311470 |
| 111 | MP0000685_abnormal_immune_system | 0.52016317 |
| 112 | MP0009785_altered_susceptibility_to | 0.51780786 |
| 113 | MP0001324_abnormal_eye_pigmentation | 0.50901843 |
| 114 | MP0003638_abnormal_response/metabolism_ | 0.50613806 |
| 115 | MP0001730_embryonic_growth_arrest | 0.50478954 |
| 116 | MP0000371_diluted_coat_color | 0.50249690 |
| 117 | MP0000579_abnormal_nail_morphology | 0.49602825 |
| 118 | MP0002060_abnormal_skin_morphology | 0.48324071 |
| 119 | MP0002909_abnormal_adrenal_gland | 0.48309851 |
| 120 | MP0002092_abnormal_eye_morphology | 0.47535918 |
| 121 | MP0006292_abnormal_olfactory_placode | 0.45836886 |
| 122 | MP0000858_altered_metastatic_potential | 0.44870182 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.44701836 |
| 124 | MP0008995_early_reproductive_senescence | 0.44698833 |
| 125 | MP0001545_abnormal_hematopoietic_system | 0.44395474 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 0.44395474 |
| 127 | MP0008872_abnormal_physiological_respon | 0.44225990 |
| 128 | MP0001697_abnormal_embryo_size | 0.44009688 |
| 129 | MP0001835_abnormal_antigen_presentation | 0.43374695 |
| 130 | MP0005025_abnormal_response_to | 0.42836515 |
| 131 | MP0003953_abnormal_hormone_level | 0.41563209 |
| 132 | MP0002928_abnormal_bile_duct | 0.41479702 |
| 133 | MP0005389_reproductive_system_phenotype | 0.41370528 |
| 134 | MP0002822_catalepsy | 0.41311847 |
| 135 | MP0001286_abnormal_eye_development | 0.41156830 |
| 136 | MP0004381_abnormal_hair_follicle | 0.41112704 |
| 137 | MP0000920_abnormal_myelination | 0.40872775 |
| 138 | MP0002166_altered_tumor_susceptibility | 0.40736691 |
| 139 | MP0008873_increased_physiological_sensi | 0.40556943 |
| 140 | MP0002796_impaired_skin_barrier | 0.39860494 |
| 141 | MP0003705_abnormal_hypodermis_morpholog | 0.39747038 |
| 142 | MP0001119_abnormal_female_reproductive | 0.38979727 |
| 143 | MP0002419_abnormal_innate_immunity | 0.35924187 |
| 144 | MP0010368_abnormal_lymphatic_system | 0.35528879 |
| 145 | MP0002098_abnormal_vibrissa_morphology | 0.35526845 |
| 146 | MP0005535_abnormal_body_temperature | 0.34100881 |
| 147 | MP0001756_abnormal_urination | 0.33403649 |
| 148 | MP0003699_abnormal_female_reproductive | 0.33091728 |
| 149 | MP0000604_amyloidosis | 0.32375188 |
| 150 | MP0003890_abnormal_embryonic-extraembry | 0.32140851 |
| 151 | MP0001873_stomach_inflammation | 0.31933613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 6.95912322 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.50127724 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.40559181 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.10514855 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.07288118 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.81479145 |
| 7 | Xanthomatosis (HP:0000991) | 5.34481038 |
| 8 | Joint hemorrhage (HP:0005261) | 4.77911521 |
| 9 | Hypolipoproteinemia (HP:0010981) | 4.77113260 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.42532090 |
| 11 | Fat malabsorption (HP:0002630) | 4.34238536 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 4.33075442 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.30765953 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.24782021 |
| 15 | Hemorrhage of the eye (HP:0011885) | 4.21895817 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 4.21876142 |
| 17 | Complement deficiency (HP:0004431) | 4.09846439 |
| 18 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.09493111 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.98749518 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.93997554 |
| 21 | Epidermoid cyst (HP:0200040) | 3.93864169 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.89671219 |
| 23 | Hyperammonemia (HP:0001987) | 3.89415652 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.86554236 |
| 25 | Hyperglycinuria (HP:0003108) | 3.77673675 |
| 26 | Hyperglycinemia (HP:0002154) | 3.69869241 |
| 27 | Hypercholesterolemia (HP:0003124) | 3.59991190 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.54546843 |
| 29 | Broad alveolar ridges (HP:0000187) | 3.51899885 |
| 30 | Abnormality of carpal bone ossification (HP:0006257) | 3.49585318 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.45789066 |
| 32 | Hyperbilirubinemia (HP:0002904) | 3.38248961 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.35339275 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.35339275 |
| 35 | Acanthocytosis (HP:0001927) | 3.33611722 |
| 36 | Ketosis (HP:0001946) | 3.33302093 |
| 37 | Small epiphyses (HP:0010585) | 3.32324768 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.29624963 |
| 39 | Vaginal fistula (HP:0004320) | 3.19583050 |
| 40 | Abnormality of complement system (HP:0005339) | 3.19405140 |
| 41 | Steatorrhea (HP:0002570) | 3.13890057 |
| 42 | Abnormal tarsal ossification (HP:0008369) | 3.13192474 |
| 43 | Hypophosphatemic rickets (HP:0004912) | 3.05010455 |
| 44 | Myocardial infarction (HP:0001658) | 2.97756691 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.97039525 |
| 46 | Poikilocytosis (HP:0004447) | 2.96423479 |
| 47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.82725123 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.76162709 |
| 49 | Broad palm (HP:0001169) | 2.75248189 |
| 50 | Malnutrition (HP:0004395) | 2.68414907 |
| 51 | Hypoglycemic seizures (HP:0002173) | 2.66204323 |
| 52 | Pigmentary retinal degeneration (HP:0001146) | 2.66124300 |
| 53 | Purpura (HP:0000979) | 2.64759096 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.64254128 |
| 55 | Abnormal hand bone ossification (HP:0010660) | 2.63873270 |
| 56 | Spontaneous abortion (HP:0005268) | 2.63820072 |
| 57 | Increased serum pyruvate (HP:0003542) | 2.63731993 |
| 58 | Opisthotonus (HP:0002179) | 2.63664279 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.60242731 |
| 60 | Metabolic acidosis (HP:0001942) | 2.56383203 |
| 61 | Menorrhagia (HP:0000132) | 2.54389651 |
| 62 | Gingival bleeding (HP:0000225) | 2.52417088 |
| 63 | Abnormal ossification of hand bones (HP:0005921) | 2.51610824 |
| 64 | Widely patent fontanelles and sutures (HP:0004492) | 2.51001812 |
| 65 | Hepatocellular carcinoma (HP:0001402) | 2.50538454 |
| 66 | Hepatoblastoma (HP:0002884) | 2.50310634 |
| 67 | Abnormality of the nasal septum (HP:0000419) | 2.50218301 |
| 68 | Potter facies (HP:0002009) | 2.46852486 |
| 69 | Facial shape deformation (HP:0011334) | 2.46852486 |
| 70 | Ketoacidosis (HP:0001993) | 2.46477701 |
| 71 | Flat acetabular roof (HP:0003180) | 2.45680831 |
| 72 | Flared iliac wings (HP:0002869) | 2.45495260 |
| 73 | Mitral stenosis (HP:0001718) | 2.41682871 |
| 74 | Abnormality of purine metabolism (HP:0004352) | 2.40812732 |
| 75 | Delayed CNS myelination (HP:0002188) | 2.40055327 |
| 76 | Vascular calcification (HP:0004934) | 2.38402862 |
| 77 | Alopecia of scalp (HP:0002293) | 2.37604486 |
| 78 | Abnormality of the lumbar spine (HP:0100712) | 2.35447829 |
| 79 | Hypochromic anemia (HP:0001931) | 2.30211291 |
| 80 | Renal cortical cysts (HP:0000803) | 2.29877372 |
| 81 | Abnormality of glycolysis (HP:0004366) | 2.28348796 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24561078 |
| 83 | Supernumerary spleens (HP:0009799) | 2.23215542 |
| 84 | Lethargy (HP:0001254) | 2.22960378 |
| 85 | Alacrima (HP:0000522) | 2.22422743 |
| 86 | Abnormality of proline metabolism (HP:0010907) | 2.21049721 |
| 87 | Hydroxyprolinuria (HP:0003080) | 2.21049721 |
| 88 | Pustule (HP:0200039) | 2.18367307 |
| 89 | Asymmetry of the thorax (HP:0001555) | 2.17789558 |
| 90 | Pancreatitis (HP:0001733) | 2.16949635 |
| 91 | Abnormal gallbladder morphology (HP:0012437) | 2.14731302 |
| 92 | Glomerulonephritis (HP:0000099) | 2.11993851 |
| 93 | Epiphyseal dysplasia (HP:0002656) | 2.11601559 |
| 94 | Osteomalacia (HP:0002749) | 2.07687503 |
| 95 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.07362872 |
| 96 | Abnormality of the alveolar ridges (HP:0006477) | 2.06341959 |
| 97 | Retinal atrophy (HP:0001105) | 2.06216623 |
| 98 | Symptomatic seizures (HP:0011145) | 2.05910914 |
| 99 | Increased mean platelet volume (HP:0011877) | 2.04885095 |
| 100 | Generalized aminoaciduria (HP:0002909) | 2.04759698 |
| 101 | Abnormal platelet volume (HP:0011876) | 2.04384800 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.04159037 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.04159037 |
| 104 | Cholelithiasis (HP:0001081) | 2.03904706 |
| 105 | Thrombophlebitis (HP:0004418) | 2.02775514 |
| 106 | Irregular epiphyses (HP:0010582) | 2.00380590 |
| 107 | Cardiovascular calcification (HP:0011915) | 1.97822179 |
| 108 | Irritability (HP:0000737) | 1.97662965 |
| 109 | Enlarged kidneys (HP:0000105) | 1.97429287 |
| 110 | Diastasis recti (HP:0001540) | 1.95856577 |
| 111 | Abnormality of the wing of the ilium (HP:0011867) | 1.95313277 |
| 112 | Abnormal foot bone ossification (HP:0010675) | 1.95236900 |
| 113 | Esophageal varix (HP:0002040) | 1.94651925 |
| 114 | Skin nodule (HP:0200036) | 1.94014005 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93293031 |
| 116 | Rectovaginal fistula (HP:0000143) | 1.92830672 |
| 117 | Rectal fistula (HP:0100590) | 1.92830672 |
| 118 | Abnormality of urine glucose concentration (HP:0011016) | 1.92390415 |
| 119 | Glycosuria (HP:0003076) | 1.92390415 |
| 120 | Abnormality of vitamin metabolism (HP:0100508) | 1.92117405 |
| 121 | Polycythemia (HP:0001901) | 1.91987461 |
| 122 | Rickets (HP:0002748) | 1.91899360 |
| 123 | Joint swelling (HP:0001386) | 1.91646738 |
| 124 | Acute hepatic failure (HP:0006554) | 1.91467705 |
| 125 | Reticulocytosis (HP:0001923) | 1.90921964 |
| 126 | Arthropathy (HP:0003040) | 1.89471678 |
| 127 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.89265878 |
| 128 | Abnormal gallbladder physiology (HP:0012438) | 1.88684478 |
| 129 | Cholecystitis (HP:0001082) | 1.88684478 |
| 130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88213861 |
| 131 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.84436187 |
| 132 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.84436187 |
| 133 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83811525 |
| 134 | Amyloidosis (HP:0011034) | 1.83487463 |
| 135 | Lower limb hyperreflexia (HP:0002395) | 1.82588723 |
| 136 | Abnormality of iron homeostasis (HP:0011031) | 1.82336425 |
| 137 | Wide cranial sutures (HP:0010537) | 1.81599817 |
| 138 | Abnormal delivery (HP:0001787) | 1.80483413 |
| 139 | Anorexia (HP:0002039) | 1.79827723 |
| 140 | Gout (HP:0001997) | 1.79613737 |
| 141 | Brushfield spots (HP:0001088) | 1.79319830 |
| 142 | Proximal tubulopathy (HP:0000114) | 1.78842125 |
| 143 | Late onset (HP:0003584) | 1.78358119 |
| 144 | Intestinal fistula (HP:0100819) | 1.77211237 |
| 145 | Abnormality of the acetabulum (HP:0003170) | 1.76012263 |
| 146 | Prenatal maternal abnormality (HP:0002686) | 1.70897936 |
| 147 | Protrusio acetabuli (HP:0003179) | 1.70761566 |
| 148 | Megaloblastic anemia (HP:0001889) | 1.69932560 |
| 149 | Abnormal connection of the cardiac segments (HP:0011545) | 1.69647913 |
| 150 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.69647913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 4.96570061 |
| 2 | FGFR3 | 4.65250032 |
| 3 | BCKDK | 3.79616873 |
| 4 | WNK4 | 3.54012304 |
| 5 | MAPK15 | 3.48340287 |
| 6 | AKT3 | 2.93875928 |
| 7 | PINK1 | 2.91526838 |
| 8 | TYRO3 | 2.69435803 |
| 9 | IRAK3 | 2.60733820 |
| 10 | FGFR4 | 2.56539010 |
| 11 | INSRR | 2.49705156 |
| 12 | CDK12 | 2.40889906 |
| 13 | MAP3K6 | 2.38987096 |
| 14 | MAP3K11 | 2.31571566 |
| 15 | ICK | 2.28663349 |
| 16 | TAOK3 | 2.28316861 |
| 17 | FGFR2 | 2.23162368 |
| 18 | MAP3K14 | 2.12993326 |
| 19 | SIK1 | 2.01035973 |
| 20 | PDK2 | 2.00438011 |
| 21 | FGFR1 | 1.97686238 |
| 22 | MAPK11 | 1.85653070 |
| 23 | ERN1 | 1.80948656 |
| 24 | PDGFRA | 1.78507846 |
| 25 | TAOK2 | 1.75941828 |
| 26 | RIPK1 | 1.73478074 |
| 27 | MST1R | 1.73394778 |
| 28 | YES1 | 1.70666256 |
| 29 | ACVR1B | 1.66297533 |
| 30 | SIK2 | 1.62189500 |
| 31 | CSK | 1.60396360 |
| 32 | EPHA2 | 1.50352434 |
| 33 | PIM2 | 1.48085608 |
| 34 | DDR2 | 1.48054499 |
| 35 | ZAK | 1.47885021 |
| 36 | FLT3 | 1.47672714 |
| 37 | ERBB4 | 1.46636177 |
| 38 | TXK | 1.41480942 |
| 39 | FRK | 1.40586686 |
| 40 | MATK | 1.40232728 |
| 41 | EIF2AK1 | 1.39175330 |
| 42 | PBK | 1.38324111 |
| 43 | DYRK1B | 1.36256623 |
| 44 | PIK3CA | 1.34949140 |
| 45 | IRAK4 | 1.34401178 |
| 46 | WNK1 | 1.34258576 |
| 47 | TYK2 | 1.33432480 |
| 48 | STK38L | 1.31455205 |
| 49 | PIM1 | 1.18568802 |
| 50 | PDPK1 | 1.17841323 |
| 51 | MAPKAPK3 | 1.17080297 |
| 52 | TRIB3 | 1.16094672 |
| 53 | MAP3K3 | 1.15785427 |
| 54 | CDK6 | 1.14043637 |
| 55 | RET | 1.13425400 |
| 56 | IKBKB | 1.04401623 |
| 57 | CHUK | 1.03504666 |
| 58 | DAPK1 | 1.02040603 |
| 59 | EEF2K | 1.01630693 |
| 60 | BMX | 0.99784264 |
| 61 | PIK3CG | 0.99734503 |
| 62 | ITK | 0.99449789 |
| 63 | CDK7 | 0.99031609 |
| 64 | TRPM7 | 0.98907529 |
| 65 | BRSK1 | 0.98820378 |
| 66 | IKBKE | 0.96714122 |
| 67 | PRPF4B | 0.95655001 |
| 68 | PRKAA2 | 0.95059750 |
| 69 | GSK3A | 0.90817596 |
| 70 | EPHA4 | 0.89230856 |
| 71 | BRD4 | 0.88220353 |
| 72 | MAP3K2 | 0.85621591 |
| 73 | TBK1 | 0.85044743 |
| 74 | MAP4K1 | 0.84307161 |
| 75 | PDK1 | 0.83383544 |
| 76 | ERBB3 | 0.81511262 |
| 77 | NUAK1 | 0.80980422 |
| 78 | RPS6KL1 | 0.80892966 |
| 79 | RPS6KC1 | 0.80892966 |
| 80 | GRK6 | 0.80456517 |
| 81 | TGFBR2 | 0.80361906 |
| 82 | LATS2 | 0.78633667 |
| 83 | RPS6KA6 | 0.78043806 |
| 84 | PRKAA1 | 0.76794775 |
| 85 | STK16 | 0.76505769 |
| 86 | MAP2K6 | 0.76087108 |
| 87 | SGK2 | 0.75266131 |
| 88 | MAPK4 | 0.73854483 |
| 89 | NEK2 | 0.72037061 |
| 90 | LATS1 | 0.71865900 |
| 91 | JAK2 | 0.70874407 |
| 92 | BMPR2 | 0.70751392 |
| 93 | PKN2 | 0.69441940 |
| 94 | TEC | 0.68515223 |
| 95 | GRK1 | 0.68247544 |
| 96 | MAP3K10 | 0.67869146 |
| 97 | RPS6KB1 | 0.67418144 |
| 98 | NEK9 | 0.67331936 |
| 99 | BTK | 0.67328481 |
| 100 | MAP2K3 | 0.67189125 |
| 101 | SGK3 | 0.67051697 |
| 102 | MAP2K2 | 0.65253379 |
| 103 | LYN | 0.65068328 |
| 104 | TNK2 | 0.65032339 |
| 105 | KSR2 | 0.64027531 |
| 106 | PLK4 | 0.63743235 |
| 107 | MAP3K1 | 0.61362086 |
| 108 | JAK1 | 0.60906987 |
| 109 | EIF2AK3 | 0.60481597 |
| 110 | CSF1R | 0.60225479 |
| 111 | CDC42BPA | 0.58915525 |
| 112 | PRKG2 | 0.58075207 |
| 113 | PRKCZ | 0.57458024 |
| 114 | PTK6 | 0.56013766 |
| 115 | BRSK2 | 0.55844382 |
| 116 | SGK494 | 0.54253811 |
| 117 | SGK223 | 0.54253811 |
| 118 | CAMK2G | 0.53482338 |
| 119 | LMTK2 | 0.53024512 |
| 120 | MAPK3 | 0.52787500 |
| 121 | EPHA3 | 0.52764527 |
| 122 | CDK4 | 0.52009334 |
| 123 | IRAK1 | 0.51595903 |
| 124 | STK39 | 0.51193643 |
| 125 | CSNK1E | 0.50383304 |
| 126 | CDK8 | 0.50341410 |
| 127 | FGR | 0.50011511 |
| 128 | ERBB2 | 0.49517991 |
| 129 | NME1 | 0.48051836 |
| 130 | JAK3 | 0.47491171 |
| 131 | CSNK2A1 | 0.45543457 |
| 132 | MST4 | 0.45292363 |
| 133 | ALK | 0.45221732 |
| 134 | CSNK2A2 | 0.45159407 |
| 135 | SMG1 | 0.44402808 |
| 136 | PRKD2 | 0.44257501 |
| 137 | PRKACG | 0.44137861 |
| 138 | EIF2AK2 | 0.42165864 |
| 139 | ATR | 0.40119056 |
| 140 | NLK | 0.39811846 |
| 141 | SRPK1 | 0.39558496 |
| 142 | STK4 | 0.39180902 |
| 143 | ZAP70 | 0.38817175 |
| 144 | RPS6KA1 | 0.38401139 |
| 145 | ADRBK2 | 0.37776297 |
| 146 | TIE1 | 0.37559964 |
| 147 | SGK1 | 0.37504351 |
| 148 | STK3 | 0.36852124 |
| 149 | CHEK2 | 0.36153983 |
| 150 | IGF1R | 0.32665772 |
| 151 | MTOR | 0.31641023 |
| 152 | MAPKAPK2 | 0.29103180 |
| 153 | MELK | 0.29041183 |
| 154 | CDK9 | 0.28706899 |
| 155 | SRC | 0.26464375 |
| 156 | CSNK1D | 0.23315128 |
| 157 | CDK1 | 0.21753955 |
| 158 | MAP3K7 | 0.21570727 |
| 159 | NTRK2 | 0.19601706 |
| 160 | LCK | 0.19572706 |
| 161 | PRKACB | 0.17270028 |
| 162 | CDK2 | 0.16482983 |
| 163 | NTRK3 | 0.16013422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.95839954 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35289853 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80670599 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.66346864 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.60573904 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57786579 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.50151264 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.37922876 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.32984530 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32064675 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.26043512 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.16998350 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13217729 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.11718098 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06123781 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.04328285 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02870809 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.02035841 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.00847606 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97476234 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.94984149 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.92730407 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.90706144 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87236191 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.84871870 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.81621128 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73794741 |
| 28 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.71550950 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.70904859 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69432587 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.67772340 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66567706 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66142607 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61696883 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60910129 |
| 36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.49530464 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.48398936 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46594091 |
| 39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.43780377 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.42035492 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.41739609 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41388344 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41033459 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.38390773 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.37371009 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.33139343 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.30263498 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.27828034 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.24083427 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23846298 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22295202 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17202640 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.16839216 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.09809365 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09232403 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08311773 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.06984001 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03382144 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02600596 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00794992 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99210044 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96436658 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95947419 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93074746 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.92063517 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82488268 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74716757 |
| 68 | * Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69869220 |
| 69 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68672697 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67094159 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63501985 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63061905 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57063248 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55253506 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53834473 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53394341 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45492081 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43525922 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41771048 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40740229 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37977129 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35665283 |
| 83 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35566989 |
| 84 | Base excision repair_Homo sapiens_hsa03410 | 0.34269766 |
| 85 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.29102767 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.28449959 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21254852 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16780819 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16486124 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.15359356 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14989840 |
| 92 | Mismatch repair_Homo sapiens_hsa03430 | 0.13272502 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.12279277 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.10485585 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.10387560 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.09559740 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.09062084 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.08048705 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.08028423 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.07772439 |
| 101 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.06445979 |
| 102 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.06247225 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05946557 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.01320535 |
| 105 | Measles_Homo sapiens_hsa05162 | -0.1163535 |
| 106 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.0979411 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0908109 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0797482 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | -0.0754217 |
| 110 | DNA replication_Homo sapiens_hsa03030 | -0.0743970 |
| 111 | Graft-versus-host disease_Homo sapiens_hsa05332 | -0.0741252 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0726922 |
| 113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | -0.0525656 |
| 114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0387647 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | -0.0359335 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0341659 |
| 117 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.0095924 |

